ClariVest Asset Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-31,060
| Closed | -$719K | – | 784 |
|
|
2023
Q1 | $719K | Sell |
31,060
-124
| -0.4% | -$2.87K | 0.03% | 329 |
|
|
2022
Q4 | $817K | Sell |
31,184
-413
| -1% | -$10.8K | 0.04% | 305 |
|
|
2022
Q3 | $621K | Buy |
31,597
+41
| +0.1% | +$806 | 0.03% | 329 |
|
|
2022
Q2 | $552K | Buy |
+31,556
| New | +$552K | 0.02% | 363 |
|
|
2022
Q1 | – | Sell |
-52,657
| Closed | -$859K | – | 798 |
|
|
2021
Q4 | $859K | Sell |
52,657
-900
| -2% | -$14.7K | 0.03% | 348 |
|
|
2021
Q3 | $684K | Sell |
53,557
-300
| -0.6% | -$3.83K | 0.02% | 382 |
|
|
2021
Q2 | $761K | Buy |
+53,857
| New | +$761K | 0.03% | 351 |
|